Fresenius SE & Co KGaA (FRE) Given a €80.00 Price Target by Warburg Research Analysts

Fresenius SE & Co KGaA (FRA:FRE) received a €80.00 ($95.24) price objective from research analysts at Warburg Research in a research note issued on Thursday. The brokerage currently has a “buy” rating on the stock. Warburg Research’s price objective would indicate a potential upside of 23.27% from the company’s previous close.

FRE has been the subject of a number of other reports. Morgan Stanley set a €83.00 ($98.81) target price on Fresenius SE & Co KGaA and gave the stock a “buy” rating in a report on Wednesday, October 4th. Kepler Capital Markets set a €63.00 ($75.00) target price on Fresenius SE & Co KGaA and gave the stock a “neutral” rating in a report on Tuesday, November 28th. Goldman Sachs Group set a €78.00 ($92.86) target price on Fresenius SE & Co KGaA and gave the stock a “neutral” rating in a report on Thursday, October 5th. UBS set a €74.00 ($88.10) target price on Fresenius SE & Co KGaA and gave the stock a “neutral” rating in a report on Tuesday, September 19th. Finally, Oddo Bhf set a €82.00 ($97.62) target price on Fresenius SE & Co KGaA and gave the stock a “buy” rating in a report on Monday, October 23rd. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of €79.60 ($94.76).

Fresenius SE & Co KGaA (FRA:FRE) opened at €64.90 ($77.26) on Thursday. Fresenius SE & Co KGaA has a twelve month low of €60.16 ($71.62) and a twelve month high of €80.00 ($95.24).

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://www.com-unik.info/2017/12/21/fresenius-se-80-00-price-target-by-warburg-research-analysts.html.

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit